Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma

Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma

Xue Yang,1,&ast; Jing Chang,2,&ast; Ruili Li,3 Yu Qi,1 Xufen Zeng,4 Wei Wang,1 Hongjun Li1 1Department of Radiology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China; 2Department of Pathology, Beijing YouAn Hospital, Capital Medical University,...

Full description

Bibliographic Details
Main Authors:	Yang X, Chang J, Li R, Qi Y, Zeng X, Wang W, Li H
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-01-01
Series:	Journal of Hepatocellular Carcinoma
Subjects:	combined hepatocellular-cholangiocarcinoma hepatocellular carcinoma computed tomography magnetic resonance imaging pathologic feature
Online Access:	https://www.dovepress.com/quantitative-assessment-of-hypovascular-component-in-arterial-phase-to-peer-reviewed-fulltext-article-JHC

Similar Items

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
by: Hai-Chun Zhang, et al.
Published: (2020-10-01)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
by: Sang Jae Noh, et al.
Published: (2012-12-01)

Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma
by: Granata Vincenza, et al.
Published: (2020-05-01)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
by: Timo Alexander Auer, et al.
Published: (2023-05-01)

Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis
by: Nayana Patil, et al.
Published: (2023-01-01)

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
by: Joon Hyuk Choi, et al.
Published: (2022-07-01)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
by: Gui‐min Hou, et al.
Published: (2022-01-01)

Current update on combined hepatocellular-cholangiocarcinoma
by: Suresh Maximin, et al.
Published: (2014-01-01)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
by: Johannes Eschrich, et al.
Published: (2023-01-01)

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
by: Takahiro Osuga, et al.
Published: (2022-03-01)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
by: Laura Schwenk, et al.
Published: (2023-07-01)

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
by: KyuHo Lee, et al.
Published: (2017-06-01)

Ataxia-telangiectasia and combined hepatocellular-cholangiocarcinoma: A case report
by: Tej P Singh, et al.
Published: (2023-01-01)

Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy
by: Yu J, et al.
Published: (2021-05-01)

Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor‐associated macrophages
by: Kun Ke, et al.
Published: (2023-10-01)

The Fibrinogen/Albumin Ratio Index as an Independent Prognostic Biomarker for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgery
by: Xu J, et al.
Published: (2022-05-01)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
by: Jennifer Sammon, et al.
Published: (2018-02-01)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
by: Marcus Bahra, et al.
Published: (2023-01-01)

Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
by: Tomoyuki Satake, et al.
Published: (2023-07-01)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
by: Florian Roßner, et al.
Published: (2023-01-01)

Double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma
by: Yi-Hsuan Hu, et al.
Published: (2020-01-01)

Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma
by: Zhuanbo Yang, et al.
Published: (2024-03-01)

Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer
by: Hyun-Jong Jang, et al.
Published: (2023-11-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
by: Lea Penzkofer, et al.
Published: (2023-01-01)

Prognostic significance of three‐tiered pathological classification for microvascular invasion in patients with combined hepatocellular‐cholangiocarcinoma following hepatic resection
by: Yijun Wu, et al.
Published: (2023-03-01)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
by: Tian MX, et al.
Published: (2019-06-01)

Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
by: Stavraka C, et al.
Published: (2018-12-01)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
by: Tao Wang, et al.
Published: (2020-12-01)

Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification
by: Minjae Kim, et al.
Published: (2021-11-01)

Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
by: Sang-Won Kim, et al.
Published: (2023-01-01)

Remarkable response of PD-1 antibody plus lenvatinib as the second-line treatment for combined hepatocellular-cholangiocarcinoma: Report of two cases
by: Zhenying Xu, et al.
Published: (2023-04-01)

A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
by: Mengmeng Wang, et al.
Published: (2018-03-01)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
by: Ning Liu, et al.
Published: (2023-11-01)

Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
by: Sven H. Loosen, et al.
Published: (2020-12-01)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
by: Daw-Shyong Perng, et al.
Published: (2021-07-01)

Clinical Imaging Characteristics and Pathological Features of Sarcomatoid Hepatocellular Carcinoma
by: Xiali ZHAI, et al.
Published: (2022-06-01)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
by: Yan Zhou, et al.
Published: (2022-05-01)

Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2022-06-01)